Published in Mol Pharmacol on January 02, 2008
Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity. Pharmacol Ther (2009) 1.63
Special article: Future directions in malignant hyperthermia research and patient care. Anesth Analg (2011) 1.61
The skeletal L-type Ca(2+) current is a major contributor to excitation-coupled Ca(2+) entry. J Gen Physiol (2009) 1.50
Differential dependence of store-operated and excitation-coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1. J Physiol (2008) 1.48
Checking your SOCCs and feet: the molecular mechanisms of Ca2+ entry in skeletal muscle. J Physiol (2009) 1.42
Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel. Hum Mol Genet (2011) 1.37
Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. Am J Physiol Cell Physiol (2009) 1.21
Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor. Proc Natl Acad Sci U S A (2012) 1.12
Alpha2delta1 dihydropyridine receptor subunit is a critical element for excitation-coupled calcium entry but not for formation of tetrads in skeletal myotubes. Biophys J (2008) 1.09
Localization of the dantrolene-binding sequence near the FK506-binding protein-binding site in the three-dimensional structure of the ryanodine receptor. J Biol Chem (2011) 1.05
Enhanced dihydropyridine receptor calcium channel activity restores muscle strength in JP45/CASQ1 double knockout mice. Nat Commun (2013) 1.04
A malignant hyperthermia-inducing mutation in RYR1 (R163C): alterations in Ca2+ entry, release, and retrograde signaling to the DHPR. J Gen Physiol (2010) 1.02
A malignant hyperthermia-inducing mutation in RYR1 (R163C): consequent alterations in the functional properties of DHPR channels. J Gen Physiol (2010) 0.98
Electrically silent divalent cation entries in resting and active voltage-controlled muscle fibers. Biophys J (2009) 0.97
The role of store-operated calcium influx in skeletal muscle signaling. Cell Calcium (2010) 0.96
Store-operated Ca2+ entry in malignant hyperthermia-susceptible human skeletal muscle. J Biol Chem (2010) 0.96
Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice. Mol Pharmacol (2010) 0.95
Structure-activity relationship of selected meta- and para-hydroxylated non-dioxin like polychlorinated biphenyls: from single RyR1 channels to muscle dysfunction. Toxicol Sci (2013) 0.92
Nonspecific sarcolemmal cation channels are critical for the pathogenesis of malignant hyperthermia. FASEB J (2012) 0.92
Basal bioenergetic abnormalities in skeletal muscle from ryanodine receptor malignant hyperthermia-susceptible R163C knock-in mice. J Biol Chem (2010) 0.91
Eccentric muscle contraction and stretching evoke mechanical hyperalgesia and modulate CGRP and P2X(3) expression in a functionally relevant manner. Pain (2010) 0.91
Halothane modulation of skeletal muscle ryanodine receptors: dependence on Ca2+, Mg2+, and ATP. Am J Physiol Cell Physiol (2008) 0.91
Critical Role of Intracellular RyR1 Calcium Release Channels in Skeletal Muscle Function and Disease. Front Physiol (2016) 0.90
Mice expressing T4826I-RYR1 are viable but exhibit sex- and genotype-dependent susceptibility to malignant hyperthermia and muscle damage. FASEB J (2011) 0.90
Ca(2+) permeation and/or binding to CaV1.1 fine-tunes skeletal muscle Ca(2+) signaling to sustain muscle function. Skelet Muscle (2015) 0.89
RGK protein-mediated impairment of slow depolarization- dependent Ca2+ entry into developing myotubes. Channels (Austin) (2014) 0.88
Ca(V)1.1: The atypical prototypical voltage-gated Ca²⁺ channel. Biochim Biophys Acta (2012) 0.88
Reduced threshold for luminal Ca2+ activation of RyR1 underlies a causal mechanism of porcine malignant hyperthermia. J Biol Chem (2008) 0.88
The cardiac alpha(1C) subunit can support excitation-triggered Ca2+ entry in dysgenic and dyspedic myotubes. Channels (Austin) (2009) 0.88
Alterations of excitation-contraction coupling and excitation coupled Ca(2+) entry in human myotubes carrying CAV3 mutations linked to rippling muscle. Hum Mutat (2011) 0.87
Divergent biophysical properties, gating mechanisms, and possible functions of the two skeletal muscle Ca(V)1.1 calcium channel splice variants. J Muscle Res Cell Motil (2011) 0.85
Malignant hyperthermia and the clinical significance of type-1 ryanodine receptor gene (RYR1) variants: proceedings of the 2013 MHAUS Scientific Conference. Can J Anaesth (2014) 0.85
Accelerated activation of SOCE current in myotubes from two mouse models of anesthetic- and heat-induced sudden death. PLoS One (2013) 0.84
Calcium entry in skeletal muscle. J Physiol (2009) 0.84
Structural and functional evaluation of branched myofibers lacking intermediate filaments. Am J Physiol Cell Physiol (2012) 0.84
Essential Role of Calmodulin in RyR Inhibition by Dantrolene. Mol Pharmacol (2015) 0.83
Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats. Int J Exp Pathol (2010) 0.83
Green tea catechins are potent sensitizers of ryanodine receptor type 1 (RyR1). Biochem Pharmacol (2010) 0.82
Gene dose influences cellular and calcium channel dysregulation in heterozygous and homozygous T4826I-RYR1 malignant hyperthermia-susceptible muscle. J Biol Chem (2011) 0.81
Disruption of action potential and calcium signaling properties in malformed myofibers from dystrophin-deficient mice. Physiol Rep (2015) 0.81
Dantrolene-induced inhibition of skeletal L-type Ca2+ current requires RyR1 expression. Biomed Res Int (2012) 0.79
Characterization of ryanodine receptor type 1 single channel activity using "on-nucleus" patch clamp. Cell Calcium (2014) 0.79
Antioxidants protect calsequestrin-1 knockout mice from halothane- and heat-induced sudden death. Anesthesiology (2015) 0.76
Baclofen in the Therapeutic of Sequele of Traumatic Brain Injury: Spasticity. Clin Neuropharmacol (2016) 0.75
New factors contributing to dynamic calcium regulation in the skeletal muscle triad-a crowded place. Biophys Rev (2009) 0.75
PharmGKB summary: very important pharmacogene information for RYR1. Pharmacogenet Genomics (2016) 0.75
Divergent Mechanisms Leading to Signaling Dysfunction in Embryonic Muscle by Bisphenol A and Tetrabromobisphenol A. Mol Pharmacol (2017) 0.75
Calcium channel blockers are inadequate for malignant hyperthermia crisis. J Anesth (2012) 0.75
A focus on extracellular Ca(2+) entry into skeletal muscle. Exp Mol Med (2017) 0.75
Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia. FASEB J (2017) 0.75
Neuroleptic malignant syndrome. Am J Psychiatry (2007) 3.64
Simultaneous recording of calcium transients in skeletal muscle using high- and low-affinity calcium indicators. Biophys J (1988) 3.21
Dantrolene--a review of its pharmacology, therapeutic use and new developments. Anaesthesia (2004) 2.50
Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J (2005) 1.97
Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology (2006) 1.97
Internal structure and visualization of transmembrane domains of the RyR1 calcium release channel by cryo-EM. Nat Struct Mol Biol (2005) 1.92
Calcium-ryanodine receptor complex. Solubilization and partial characterization from skeletal muscle junctional sarcoplasmic reticulum vesicles. J Biol Chem (1986) 1.83
The effect of repetitive stimulation at low frequencies upon the electrical and mechanical activity of single muscle fibres. Pflugers Arch (1972) 1.81
Receptor-activated Ca2+ influx. Two independently regulated mechanisms of influx stimulation coexist in neurosecretory PC12 cells. J Biol Chem (1992) 1.80
Involvement of multiple intracellular release channels in calcium sparks of skeletal muscle. Proc Natl Acad Sci U S A (2000) 1.78
Managing an effective treatment for neuroleptic malignant syndrome. Crit Care (2007) 1.73
Regulation of mammalian ryanodine receptors. Front Biosci (2002) 1.72
Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line. Biophys J (2000) 1.69
Characterization of multiple [3H]ryanodine binding sites on the Ca2+ release channel of sarcoplasmic reticulum from skeletal and cardiac muscle: evidence for a sequential mechanism in ryanodine action. Mol Pharmacol (1991) 1.66
Dantrolene inhibition of ryanodine receptor Ca2+ release channels. Molecular mechanism and isoform selectivity. J Biol Chem (2001) 1.63
Postulated role of interdomain interaction within the ryanodine receptor in Ca(2+) channel regulation. J Biol Chem (2000) 1.59
Effects of external calcium deprivation on single muscle fibers. J Gen Physiol (1967) 1.55
Dantrolene stabilizes domain interactions within the ryanodine receptor. J Biol Chem (2004) 1.52
Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc Natl Acad Sci U S A (2004) 1.51
Azumolene inhibits a component of store-operated calcium entry coupled to the skeletal muscle ryanodine receptor. J Biol Chem (2006) 1.46
Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic review. J Pain Symptom Manage (2004) 1.41
Dyspedic mouse skeletal muscle expresses major elements of the triadic junction but lacks detectable ryanodine receptor protein and function. J Biol Chem (1997) 1.39
Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem (2003) 1.38
Identification of a dantrolene-binding sequence on the skeletal muscle ryanodine receptor. J Biol Chem (2002) 1.34
Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers. J Gen Physiol (2001) 1.32
Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at skeletal muscle ryanodine receptors. J Biol Chem (1997) 1.24
Peptide probe study of the critical regulatory domain of the cardiac ryanodine receptor. Biochem Biophys Res Commun (2002) 1.22
Ca2+ sparks and T tubule reorganization in dedifferentiating adult mouse skeletal muscle fibers. Am J Physiol Cell Physiol (2006) 1.20
Diagnosis and management of acute movement disorders. J Neurol (2005) 1.16
Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology (1983) 1.15
Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor. Biochemistry (2002) 1.15
Elevated resting [Ca(2+)](i) in myotubes expressing malignant hyperthermia RyR1 cDNAs is partially restored by modulation of passive calcium leak from the SR. Am J Physiol Cell Physiol (2006) 1.14
Ryanodine induces persistent inactivation of the Ca2+ release channel from skeletal muscle sarcoplasmic reticulum. Mol Pharmacol (1992) 1.14
Methods for myoblast transplantation. Methods Cell Biol (1997) 1.12
Ryanodine receptor type 1 (RyR1) mutations C4958S and C4961S reveal excitation-coupled calcium entry (ECCE) is independent of sarcoplasmic reticulum store depletion. J Biol Chem (2005) 1.11
Structural aspects of ryanodine action and selectivity. J Med Chem (1987) 1.01
Identification of dantrolene binding sites in porcine skeletal muscle sarcoplasmic reticulum. J Biol Chem (1995) 0.99
Diketopyridylryanodine has three concentration-dependent effects on the cardiac calcium-release channel/ryanodine receptor. J Biol Chem (2003) 0.99
A postulated role of the near amino-terminal domain of the ryanodine receptor in the regulation of the sarcoplasmic reticulum Ca(2+) channel. J Biol Chem (1999) 0.99
The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling. Biochemistry (2001) 0.98
Malignant hyperthermia. Best Pract Res Clin Anaesthesiol (2003) 0.97
Effects of azumolene on Ca2+ sparks in skeletal muscle fibers. J Pharmacol Exp Ther (2005) 0.96
Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing? Eur J Hum Genet (2003) 0.92
Pharmacotherapy of spasticity in children with cerebral palsy. Pediatr Neurol (2006) 0.91
Compartmental pharmacokinetics of dantrolene in adults: do malignant hyperthermia association dosing guidelines work? Anesth Analg (2005) 0.90
Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia. Biochem J (2007) 0.90
Effects of dantrolene on myoplasmic free [Ca2+] measured in vivo in patients susceptible to malignant hyperthermia. Anesthesiology (1992) 0.89
Motor neuron targeting of IGF-1 attenuates age-related external Ca2+-dependent skeletal muscle contraction in senescent mice. Exp Gerontol (2006) 0.89
Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology (2001) 0.89
Pharmacological distinction between dantrolene and ryanodine binding sites: evidence from normal and malignant hyperthermia-susceptible porcine skeletal muscle. Biochem J (1997) 0.88
Successful treatment of a complicated case of neuroleptic malignant syndrome. Intensive Care Med (2002) 0.88
[3H]Azidodantrolene: synthesis and use in identification of a putative skeletal muscle dantrolene binding site in sarcoplasmic reticulum. J Med Chem (1999) 0.86
Malignant hyperthermia in dogs. J Am Vet Med Assoc (1991) 0.85
Dantrolene prevents the malignant hyperthermic syndrome by reducing free intracellular calcium concentration in skeletal muscle of susceptible swine. Cell Calcium (1987) 0.84
The action of ryanodine on mammalian skeletal muscle in situ. J Pharmacol Exp Ther (1956) 0.84
Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+ ]. Anesthesiology (2000) 0.83
The effect of ryanodine on the contractile strength of mammalian cardiac (atrial) muscle. J Pharmacol Exp Ther (1959) 0.79
The pharmacological management of spasticity. J Neurosci Nurs (2006) 0.79
Effect of dantrolene treatment on muscle metabolism and meat quality of anesthetized pigs of different halothane genotypes. J Anim Sci (1994) 0.78
[Determination of intracellular free calcium concentration, in vivo, in swine susceptible to malignant hyperthermia syndrome]. Acta Cient Venez (1985) 0.78
Some pharmacological actions of ryanodine in the mammal. J Pharmacol Exp Ther (1958) 0.77
Dantrolene reduces myoplasmic free [Ca2+] in patients with malignant hyperthermia. Acta Cient Venez (1990) 0.77
The reduction of skeletal muscle lesions after experimental stress in stress-susceptible pigs protected with dantrolene. Zentralbl Veterinarmed A (1995) 0.76
Timing of new black box warnings and withdrawals for prescription medications. JAMA (2002) 9.65
Altered microRNA expression in human heart disease. Physiol Genomics (2007) 5.64
The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect (2006) 3.81
New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14
Leaky Ca2+ release channel/ryanodine receptor 2 causes seizures and sudden cardiac death in mice. J Clin Invest (2008) 2.45
Mitochondrial dysfunction in autism. JAMA (2010) 2.04
A functional insulin-like growth factor receptor is not necessary for load-induced skeletal muscle hypertrophy. J Physiol (2007) 2.03
Three-dimensional distribution of ryanodine receptor clusters in cardiac myocytes. Biophys J (2006) 2.03
Heat- and anesthesia-induced malignant hyperthermia in an RyR1 knock-in mouse. FASEB J (2005) 1.97
Pharmacologic and functional characterization of malignant hyperthermia in the R163C RyR1 knock-in mouse. Anesthesiology (2006) 1.97
MORC family ATPases required for heterochromatin condensation and gene silencing. Science (2012) 1.97
Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet (2010) 1.95
Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun (2008) 1.89
Autism: maternally derived antibodies specific for fetal brain proteins. Neurotoxicology (2007) 1.87
Isolated coronary artery bypass graft combined with bone marrow mononuclear cells delivered through a graft vessel for patients with previous myocardial infarction and chronic heart failure: a single-center, randomized, double-blind, placebo-controlled clinical trial. J Am Coll Cardiol (2011) 1.85
In vitro biologic activities of the antimicrobials triclocarban, its analogs, and triclosan in bioassay screens: receptor-based bioassay screens. Environ Health Perspect (2008) 1.82
Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun (2008) 1.79
Reorganized stores and impaired calcium handling in skeletal muscle of mice lacking calsequestrin-1. J Physiol (2007) 1.78
Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating. PLoS Biol (2009) 1.77
An RCS-like retinal dystrophy phenotype in mer knockout mice. Invest Ophthalmol Vis Sci (2003) 1.75
PDZ domains of Par-3 as potential phosphoinositide signaling integrators. Mol Cell (2007) 1.70
Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice. Toxicol Sci (2007) 1.68
NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates calcium-induced calcium release. Circ Res (2003) 1.67
Heart and skeletal muscle are targets of dengue virus infection. Pediatr Infect Dis J (2010) 1.67
The balance between capture and dissociation of presynaptic proteins controls the spatial distribution of synapses. Neuron (2013) 1.62
MERTK arginine-844-cysteine in a patient with severe rod-cone dystrophy: loss of mutant protein function in transfected cells. Invest Ophthalmol Vis Sci (2004) 1.61
Luminescent chemodosimeters for bioimaging. Chem Rev (2012) 1.61
Aryl hydrocarbon receptor signaling regulates NF-κB RelB activation during dendritic-cell differentiation. Immunol Cell Biol (2013) 1.60
Neuromuscular synaptic patterning requires the function of skeletal muscle dihydropyridine receptors. Nat Neurosci (2011) 1.58
Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci U S A (2009) 1.57
Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. Physiol Genomics (2002) 1.57
Gene expression changes in children with autism. Genomics (2007) 1.55
Altered T cell responses in children with autism. Brain Behav Immun (2010) 1.53
Conformational activation of Ca2+ entry by depolarization of skeletal myotubes. Proc Natl Acad Sci U S A (2004) 1.51
Sub-10 nm hexagonal lanthanide-doped NaLuF4 upconversion nanocrystals for sensitive bioimaging in vivo. J Am Chem Soc (2011) 1.51
The skeletal L-type Ca(2+) current is a major contributor to excitation-coupled Ca(2+) entry. J Gen Physiol (2009) 1.50
Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function. J Thorac Cardiovasc Surg (2008) 1.49
Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle. J Biol Chem (2007) 1.48
Myosin VI undergoes cargo-mediated dimerization. Cell (2009) 1.47
Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders. J Neuroimmunol (2010) 1.46
Lymphocytes from patients with type 1 diabetes display a distinct profile of chromatin histone H3 lysine 9 dimethylation: an epigenetic study in diabetes. Diabetes (2008) 1.46
Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT. Radiology (2014) 1.43
Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol (2008) 1.41
Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis. Tumour Biol (2014) 1.39
Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J Biol Chem (2003) 1.38
Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol (2002) 1.38
PBDEs in 2-5 year-old children from California and associations with diet and indoor environment. Environ Sci Technol (2010) 1.38
Shape-selective synthesis and oxygen storage behavior of ceria nanopolyhedra, nanorods, and nanocubes. J Phys Chem B (2005) 1.37
Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res (2008) 1.37
Expression levels of RyR1 and RyR3 control resting free Ca2+ in skeletal muscle. Am J Physiol Cell Physiol (2004) 1.36
Mertk drives myosin II redistribution during retinal pigment epithelial phagocytosis. Invest Ophthalmol Vis Sci (2008) 1.35
Formulation and characterization of an experimental PCB mixture designed to mimic human exposure from contaminated fish. Toxicol Sci (2005) 1.32
Increased IgG4 levels in children with autism disorder. Brain Behav Immun (2008) 1.32
Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol (2005) 1.32
Structural characterization of the RyR1-FKBP12 interaction. J Mol Biol (2005) 1.30
Generation of iPS cells using defined factors linked via the self-cleaving 2A sequences in a single open reading frame. Cell Res (2009) 1.29
Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am J Physiol Cell Physiol (2004) 1.28
Age-related hearing loss in C57BL/6J mice has both frequency-specific and non-frequency-specific components that produce a hyperacusis-like exaggeration of the acoustic startle reflex. J Assoc Res Otolaryngol (2007) 1.27
Developmental exposure to polychlorinated biphenyls interferes with experience-dependent dendritic plasticity and ryanodine receptor expression in weanling rats. Environ Health Perspect (2008) 1.27
Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia (2012) 1.26
Conformation-dependent stability of junctophilin 1 (JP1) and ryanodine receptor type 1 (RyR1) channel complex is mediated by their hyper-reactive thiols. J Biol Chem (2007) 1.25
Tipping the balance of autism risk: potential mechanisms linking pesticides and autism. Environ Health Perspect (2012) 1.25
Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. Blood (2010) 1.24
Premutation CGG-repeat expansion of the Fmr1 gene impairs mouse neocortical development. Hum Mol Genet (2010) 1.24
Global increases in both common and rare copy number load associated with autism. Hum Mol Genet (2013) 1.24
Functional coupling between TRPC3 and RyR1 regulates the expressions of key triadic proteins. J Biol Chem (2006) 1.23
Multiple regions of RyR1 mediate functional and structural interactions with alpha(1S)-dihydropyridine receptors in skeletal muscle. Biophys J (2002) 1.23
The ryanodine receptor modulates the spontaneous beating rate of cardiomyocytes during development. Proc Natl Acad Sci U S A (2002) 1.23
Enhanced excitation-coupled calcium entry in myotubes is associated with expression of RyR1 malignant hyperthermia mutations. J Biol Chem (2007) 1.22
Critical amino acid residues determine the binding affinity and the Ca2+ release efficacy of maurocalcine in skeletal muscle cells. J Biol Chem (2003) 1.22
Bidirectional signaling between calcium channels of skeletal muscle requires multiple direct and indirect interactions. Proc Natl Acad Sci U S A (2006) 1.22
Malformed mdx myofibers have normal cytoskeletal architecture yet altered EC coupling and stress-induced Ca2+ signaling. Am J Physiol Cell Physiol (2009) 1.21
Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc Res (2010) 1.21
Trophoblast inclusions are significantly increased in the placentas of children in families at risk for autism. Biol Psychiatry (2013) 1.21
Ca2+ sparks and T tubule reorganization in dedifferentiating adult mouse skeletal muscle fibers. Am J Physiol Cell Physiol (2006) 1.20
Upconversion luminescent materials: advances and applications. Chem Rev (2014) 1.19
MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res (2008) 1.19
Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors. Environ Health Perspect (2009) 1.19
Signaling defects in iPSC-derived fragile X premutation neurons. Hum Mol Genet (2012) 1.19
Evidence for conformational coupling between two calcium channels. Proc Natl Acad Sci U S A (2004) 1.18
RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes. J Biol Chem (2010) 1.18
Highly responsive ultrathin GaS nanosheet photodetectors on rigid and flexible substrates. Nano Lett (2013) 1.18
Maurocalcine and peptide A stabilize distinct subconductance states of ryanodine receptor type 1, revealing a proportional gating mechanism. J Biol Chem (2003) 1.17
Principles and practices of neurodevelopmental assessment in children: lessons learned from the Centers for Children's Environmental Health and Disease Prevention Research. Environ Health Perspect (2005) 1.17
Hemicalcin, a new toxin from the Iranian scorpion Hemiscorpius lepturus which is active on ryanodine-sensitive Ca2+ channels. Biochem J (2007) 1.17
The effects of multi-domain versus single-domain cognitive training in non-demented older people: a randomized controlled trial. BMC Med (2012) 1.16
Clustered burst firing in FMR1 premutation hippocampal neurons: amelioration with allopregnanolone. Hum Mol Genet (2012) 1.15